Novartis Ups Forecast on Lack of Diovan Competitor

July 17 (Bloomberg) -- Novartis AG raised its full-year forecast as generic competition for the Diovan blood-pressure drug failed to materialize in the U.S. Sam Fazeli reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
Rick Perry Lays Down a Challenge to Donald Trump
34:37 - On "With All Due Respect," Mark Halperin and John Heilemann discuss Rick Perry’s response to Donald trump’s remarks that the former Texas governor doesn’t belong on the main debate stage.
  • The Possibilities of 3D Printed Skin
  • Why Akamai Is Betting on Netflix Rivals
  • Alibaba to Invest $1B in Cloud-Computing Service Aliyun